This clinical trial is focused on studying the safety and effectiveness of a group of substances known as Metal Panel Allergens. These substances are used to test for allergic contact dermatitis, a type of skin reaction that occurs when the skin comes into contact with certain metals. The study will use a special patch test to apply these allergens to the skin. The allergens being tested include Nickel Sulfate, Copper Sulfate, Tin Chloride, Manganese Chloride, Zinc Chloride, Cobalt Chloride, Gold Sodium Thiosulfate, Sodium Tetrachloropalladate, Vanadium Oxide Sulfate, Ammonium Titanium Oxalate, and Potassium Dichromate. These substances are applied to the skin using a device called the allergEAZE Patch Test Chamber, which helps to deliver the allergens in a controlled manner.
The purpose of the study is to evaluate how well these allergens can diagnose allergic contact dermatitis and to ensure they are safe to use. Participants will have the allergens applied to their skin in the form of patches, which will remain in place for a short period. The study will monitor any skin reactions that occur, which can help determine if a person is allergic to any of the metals tested. The study will also compare the results of this patch test method with a reference method to see how well they agree.
The trial will take place over a period of time, with participants being monitored for any reactions to the allergens. The study aims to provide valuable information on the safety and performance of these metal allergens in diagnosing allergic contact dermatitis. This information could help improve the way allergies to metals are diagnosed and managed in the future.



Germany
Italy
The Netherlands